Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v5-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2025-01-06 | 2025-01-06 |
| Drug Identification Number | 02371588 | 02371588 |
| Brand name | OVIDREL | OVIDREL |
| Common or Proper name | Choriogonadotropin alfa | Choriogonadotropin alfa |
| Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA | EMD SERONO, A DIVISION OF EMD INC., CANADA |
| Ingredients | CHORIOGONADOTROPIN ALFA | CHORIOGONADOTROPIN ALFA |
| Strength(s) | 250MCG | 250MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 1 pen | 1 pen |
| ATC code | G03GA | G03GA |
| ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2024-08-30 | 2024-08-30 |
| Actual start date | 2024-09-02 | 2024-09-02 |
| Estimated end date | 2025-12-31 | 2025-12-31 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | OVIDREL SYRINGE (DIN 02262088) remains available | OVIDREL SYRINGE (DIN 02262088) remains available |
| Health Canada comments |